PRP Survival Guide

papabill

Haystack with two large needles, scenic background.

PRP Research at OHSU Update: July 3, 2018

On May 9, 2018 — nearly two months ago — I posted messages to the PRP Facebook and RareConnect communities announcing that Dr. Teri Greiling, Assistant Professor of Dermatology at Oregon Health and Science University in Portland, Oregon, had been given the green light to treat 15 PRP patients with Taltz® (Ixekizumab, a biological manufactured by Lilly. I created a

PRP Research at OHSU Update: July 3, 2018 Read More »

OHSU PRP Research logo with abstract design.

OHSU Studies PRP and Taltz (ixekizumab)

From the Editor… Nearly two years ago (May 17, 2017) I received an email from Dr. Teri Greiling,  Assistant Professor of Dermatology at Oregon Health and Science University in Portland, Oregon. Like every PRP patient and caregiver, Dr. Greiling lamented the fact that not a single therapeutic trial had ever been conducted for patients with PRP. She also

OHSU Studies PRP and Taltz (ixekizumab) Read More »